FTRE Form 4: Robert Parks RSU Settlement and Sell-to-Cover Transaction
Rhea-AI Filing Summary
Fortrea Holdings (FTRE) insider Robert Parks reported settlement and partial sale of restricted stock units. On 09/08/2025 Mr. Parks had 2,042 RSUs settle into 2,042 shares of common stock, increasing his direct holdings to 92,655 RSUs (aggregate RSU count) and 2,042 shares reported following settlement. On 09/09/2025 he executed a sell-to-cover of 592 shares at a weighted-average price of $10.23 to satisfy tax withholding, leaving 1,450 shares held directly. The RSUs vested on 09/06/2025 with a remaining installment vesting 09/06/2026. All trades were routine equity-compensation transactions and the sales were not discretionary.
Positive
- Recorded settlement of 2,042 RSUs into Common Stock on the scheduled vesting date, reflecting compensation realization
- Disclosure specifies weighted-average sale price range ($10.02–$10.44) and weighted-average price ($10.23), enabling transparency
Negative
- A mandatory sell-to-cover resulted in the sale of 592 shares, reducing direct holdings to 1,450 shares
- Filing shows significant outstanding RSU balance (92,655 RSUs aggregate), which may result in future share issuances upon vesting
Insights
TL;DR: Routine insider settlement and sell-to-cover; modest net share increase but no material change to ownership.
The filing documents the scheduled vesting and settlement of 2,042 RSUs into common stock and a consequent mandatory sell-to-cover of 592 shares at a weighted-average price of $10.23. The net direct shares held by the reporting person after these transactions is 1,450 shares, with 92,655 RSUs (aggregate) remaining. These are standard equity-compensation mechanics that do not indicate voluntary market timing or a material change in beneficial ownership given the sizes disclosed.
TL;DR: Compensation-driven transactions consistent with plan terms; disclosure is complete and clear.
The Form 4 clearly states the RSU settlement, the mandatory nature of the sell-to-cover to satisfy tax obligations, and provides the weighted-average sale price range. The filing discloses the vesting schedule (next installment 09/06/2026) and is signed by an attorney-in-fact. From a governance perspective, this is a routine officer disclosure without indications of atypical executive selling behavior.